Miseq reagent kits
Ended Awarded Last action
- Contract number
- HHSF22301076T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $111,993
Award facts
- Contract value 100% obligated
- $111,993.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a delivery order valued at $111,993.35 to Illumina, Inc. for MiSeq reagent kits under a firm fixed-price contract. The order was placed on June 7, 2017, with an ultimate completion date of September 30, 2017, and will be performed at Illumina's San Diego, California facility. No set-aside designation was applied to this award. MiSeq reagent kits are consumable products used with Illumina's MiSeq DNA sequencing systems to enable genomic analysis and sequencing operations within the FDA's laboratory and research operations.
Illumina, Inc. is a San Diego-based biotechnology manufacturer specializing in genetic sequencing and genomic analysis technologies that serve federal research and diagnostic initiatives. As an established federal contractor since 2001, the company provides a comprehensive portfolio of sequencing instruments, reagent kits, and bioinformatics software to civilian agencies including the FDA, National Institutes of Health, Department of Agriculture, and Environmental Protection Agency. This delivery order represents a routine procurement of consumable reagents supporting the FDA's ongoing genomic research and diagnostic capabilities, consistent with Illumina's role as a primary technology provider for federal genomic sequencing initiatives.
Quick answers
Who was awarded contract HHSF22301076T?
HHSF22301076T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 7, 2017.
How much is contract HHSF22301076T worth?
The government has obligated $111,993 on HHSF22301076T.
Is contract HHSF22301076T an order under another contract?
Yes. HHSF22301076T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301076T competed?
The extent of competition for HHSF22301076T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award